{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:08Z","timestamp":1792182308952,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ajp.2020.101950","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T19:51:57Z","timestamp":1582055517000},"page":"101950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Clozapine associated cardiotoxicity: Issues, challenges and way forward"],"prefix":"10.1016","volume":"50","author":[{"given":"Guna","family":"Kanniah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2020.101950_bib0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2014.07.103","article-title":"A systematic review of clozapine induced cardiomyopathy","volume":"176","author":"Alawami","year":"2014","journal-title":"Int J Cardiol. 2."},{"issue":"5 Pt 2","key":"10.1016\/j.ajp.2020.101950_bib0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1399-5618.2006.00344.x","article-title":"Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review","volume":"8","author":"Baldessarini","year":"2006","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.ajp.2020.101950_bib0015","first-page":"1","article-title":"Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia: a multicentre cross-sectional cohort study","volume":"26","author":"Chow","year":"2014","journal-title":"Open Heart"},{"issue":"6982","key":"10.1016\/j.ajp.2020.101950_bib0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ajp.2020.101950_bib0025","article-title":"A Case of Clozapine-Induced Myocarditis in a Young Patient with Bipolar Disorder","author":"Cohen","year":"2015","journal-title":"Case Rep. Cardiol."},{"issue":"6","key":"10.1016\/j.ajp.2020.101950_bib0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.psym.2015.07.002","article-title":"Clozapine-induced myocarditis: prevention and considerations in rechallenge","volume":"56","author":"Cook","year":"2015","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1016\/j.ajp.2020.101950_bib0035","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0003-3928(02)00136-1","article-title":"Reversible cardiomyopathy induced by psychotropic drugs: case report and literature overview","volume":"51","author":"Cruchaudet","year":"2012","journal-title":"Ann Cardiol Angeiol (Paris)."},{"issue":"5","key":"10.1016\/j.ajp.2020.101950_bib0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/YIC.0000000000000085","article-title":"Impairment of left ventricular function early in treatment with clozapine: a preliminary study","volume":"30","author":"Curto","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.ajp.2020.101950_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-016-0704-3","article-title":"Systematic review of clozapine cardiotoxicity","volume":"18","author":"Curto","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"issue":"3","key":"10.1016\/j.ajp.2020.101950_bib0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/2211556008666190916093915","article-title":"Sudden death associated with complex treatment of acute mania: case report and toxicological findings","volume":"8","author":"Curto","year":"2019","journal-title":"Curr Psychopharmacology."},{"issue":"7","key":"10.1016\/j.ajp.2020.101950_bib0055","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajp.2020.101950_bib0060","first-page":"11","article-title":"Clozapine-induced myocarditis","volume":"1","author":"Datta","year":"2018","journal-title":"Oxf. Med. Case Reports"},{"issue":"4","key":"10.1016\/j.ajp.2020.101950_bib0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/acps.12421","article-title":"Titrating clozapine amidst recommendations proposing high myocarditis risk and rapid titrations","volume":"132","author":"de Leon","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.ajp.2020.101950_bib0070","first-page":"8","article-title":"Barriers to using clozapine in treatment-resistant schizophrenia: systematic review","volume":"43","author":"Farooq","year":"2019","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2020.101950_bib0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/acps.12425","article-title":"Clozapine-induced myocarditis: prescribe safely but do prescribe","volume":"132","author":"Freudenreich","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"2\u20133","key":"10.1016\/j.ajp.2020.101950_bib0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.schres.2004.05.015","article-title":"Suicidal risk during treatment with clozapine: a meta-analysis","volume":"73","author":"Hennen","year":"2005","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.ajp.2020.101950_bib0085","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"10.1016\/j.ajp.2020.101950_bib0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3371\/1935-1232-10.2.120","article-title":"Rapid Re-challenge with clozapine following pronounced myocarditis in a treatment-resistance schizophrenia patient","volume":"10","author":"Ittasakul","year":"2016","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"9","key":"10.1016\/j.ajp.2020.101950_bib0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9193","key":"10.1016\/j.ajp.2020.101950_bib0100","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet."},{"issue":"11","key":"10.1016\/j.ajp.2020.101950_bib0105","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1176\/appi.ajp.158.11.1930","article-title":"Elevated clozapine plasma level with lamotrigine","volume":"158","author":"Kossen","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2020.101950_bib0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-859X-4-10","article-title":"N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment","volume":"4","author":"Kropp","year":"2005","journal-title":"Ann. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2020.101950_bib0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5694\/j.1326-5377.2009.tb02345.x","article-title":"Clozapine-induced cardiotoxicity: a clinical update","volume":"190","author":"Layland","year":"2009","journal-title":"Med J Australia."},{"issue":"4","key":"10.1016\/j.ajp.2020.101950_bib0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jac\/dkl557","article-title":"HLA-B*5701 screening for susceptibility to abacavir hypersensitivity","volume":"59","author":"Lucas","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.ajp.2020.101950_bib0125","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.ajp.2020.101950_bib0130","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2147\/NDT.S49028","article-title":"Clozapine reinitiation following a \u201cred result\u201d secondary to chemotherapy","volume":"2013","author":"Munshi","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.ajp.2020.101950_bib0135","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1378\/chest.126.5.1703","article-title":"Clozapine-induced hypersensitivity myocarditis","volume":"126","author":"Pieroni","year":"2004","journal-title":"Chest."},{"issue":"11\u201312","key":"10.1016\/j.ajp.2020.101950_bib0140","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/j.1440-1614.2004.01481.x","article-title":"Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service","volume":"38","author":"Reinders","year":"2004","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2020.101950_bib0145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/00048674.2011.572852","article-title":"A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls","volume":"45","author":"Ronaldson","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.ajp.2020.101950_bib0150","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/0004867411433970","article-title":"Continuation of clozapine following mild myocarditis","volume":"46","author":"Ronaldson","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.ajp.2020.101950_bib0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2012.08.018","article-title":"Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study","volume":"141","author":"Ronaldson","year":"2012","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.ajp.2020.101950_bib0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/acps.12416","article-title":"Clozapine-induced myocarditis, a widely overlooked adverse reaction","volume":"132","author":"Ronaldson","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"12","key":"10.1016\/j.ajp.2020.101950_bib0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM199709183371202","article-title":"A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia","volume":"337","author":"Rosenheck","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ajp.2020.101950_bib0170","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/JCP.0b013e318234ee66","article-title":"Usefulness of NT-Pro-BNP and echocardiography in the diagnosis of subclinical clozapine-related cardiotoxicity","volume":"31","author":"Rostagno","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2020.101950_bib0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1017\/S1742646413000332","article-title":"Drug interactions affecting clozapine levels","volume":"11","author":"Singh","year":"2013","journal-title":"J. Psychiatr. Intensive Care"},{"issue":"1\u20133","key":"10.1016\/j.ajp.2020.101950_bib0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2016.04.016","article-title":"Clozapine-induced myocarditis","volume":"174","author":"Swart","year":"2016","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.ajp.2020.101950_bib0185","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MJT.0b013e3181822564","article-title":"Sinus node dysfunction in association with chronic lithium therapy: a case report and review of literature","volume":"16","author":"Talati","year":"2009","journal-title":"Am. J. Ther."},{"issue":"2","key":"10.1016\/j.ajp.2020.101950_bib0190","first-page":"75","article-title":"Subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"10","author":"Thyagarajan","year":"2016","journal-title":"Us Cardiol. Rev."},{"issue":"9690","key":"10.1016\/j.ajp.2020.101950_bib0195","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.ajp.2020.101950_bib0200","article-title":"Clozapine and myocarditis","volume":"26","author":"Topliss","year":"2007","journal-title":"Australian Adverse Drug Reactions Bulletin."},{"issue":"9","key":"10.1016\/j.ajp.2020.101950_bib0205","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1176\/ajp.152.9.1401b","article-title":"Pharmacokinetic interaction between risperidone and clozapine","volume":"152","author":"Tyson","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2020.101950_bib0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/JCP.0b013e318191c6a8","article-title":"Psychotropic drugs associated with corrected QT interval prolongation","volume":"29","author":"van Noord","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.ajp.2020.101950_bib0215","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1176\/ajp.156.7.990","article-title":"Evidence of clozapine\u2019s effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials","volume":"156","author":"Wahlbeck","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2020.101950_bib0220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1742-7843.2007.00054.x","article-title":"Delayed cardiotoxicity in chronic lithium poisoning: discrepancy between serum lithium concentrations and clinical status","volume":"100","author":"Waring","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.ajp.2020.101950_bib0225","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/1039856215604480","article-title":"Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia","volume":"24","author":"Youssef","year":"2016","journal-title":"Australas. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201820300587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201820300587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:34:13Z","timestamp":1761755653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201820300587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":45,"alternative-id":["S1876201820300587"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2020.101950","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine associated cardiotoxicity: Issues, challenges and way forward","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2020.101950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101950"}}